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Abstract Lipids are a complex group of chemical com-
pounds that are a significant component of the human diet
and are one of the main constituents of milk. In mammals,
lipids are produced in the milk-secreting cells in the form of
milk fat globules. The chemical properties of these com-
pounds necessitate developing separate processes for effective
management of non-polar substances in the polar environment
of the cell, not only during their biosynthesis and accumula-
tion in the cell interior and secretion of intracytoplasmic lipid
droplets outside the cell, but also during digestion in the off-
spring. Phospholipids play an important role in these process-
es. Their characteristic properties make them indispensable for
the secretion of milk fat as well as other milk components.
This review investigates how these processes depend on the
coordinated flux and availability of phospholipids and how
the relationship between the surface area (phospholipids)
and volume (neutral lipids) of the cytoplasmic lipid droplets
must be in biosynthetic balance. The structure formed as a
result (i.e. a milk fat globule) is therefore a result of specified
structural limitations inside the cell, whose overcoming en-
ables the coordinated secretion of milk components. This
structure and its composition also reflects the nutritional de-
mands of the developing infant organism as a result of evolu-
tionary adaptation.
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MUC mucin
XDH/XO xanthine dehydrogenase/oxidase
PAS periodic acid Schiff
CD cluster of differentiation
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EGF epidermal growth factor
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FABP fatty acid binding protein
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SREBP sterol regulatory element-binding protein
SCAP SREBP cleavage activating protein
PPAR peroxisome proliferator-activated receptor
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SNAP soluble NSF attachment protein
SNARE soluble NSF attachment protein receptor
CIDE cell death-inducing DNA
fragmentation factor 45-like effector
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An increasing number of studies have demonstrated that
breastfeeding is one of the key factors affecting the health of
infants and has a positive impact on mothers by minimizing
the likelihood of breast and ovarian cancer [1, 2]. This synergis-
tic, positive effect on both the baby and the mother results from
evolutionary adaptation and development of mechanisms indis-
pensable for ensuring the best possible conditions for progeny
development.
One of the constituents of milk are lipid compounds, which
are an important component of the human diet throughout the
whole life. Lipids are a complex group of chemical compounds,
the significance and role of which are probably the least recog-
nized among all groups of biomolecules. Due to their complex
composition and incomplete knowledge in this regard, it is dif-
ficult to define the nutritional recommendations concerning this
group of compounds, even though they constitute a significant
part of the cell metabolome. The reason for this may be slower
progression in available instrumentation to adequately character-
ize complex lipid fingerprints. Genetic and bioinformatic
methods are not very useful in the analysis of lipids since they
are not directly linked with the body genome. Therefore, prog-
ress in this research area is proceeding slightly slower than other
classes of biomolecules [3]. Although lipid diagnostics has long
been applied in medicine (blood levels of cholesterol, lipopro-
teins or triacylglycerols), the structural foundations of the role of
qualitative composition of these compounds remain largely un-
explained. Although our knowledge of multiple lipid roles is
increasing, more research is needed to understand the unique
attributes of structurally specific lipid species in relation to cell
function. This indicates the necessity for the development of this
research area, all the more that one of the basic functions of
lipids is providing and accumulating energy and that an excess
of energy reserves in the human body poses one of the major
nutritional problems facing the contemporary generation.
Milk lipids in the form of milk fat globules (MFG) are pro-
duced in themilk-secreting cells, a single layer of which lines the
internal walls of mammary gland cavities, called alveoli. The
diversity of synthesized lipids and complexity of biosynthetic
mechanisms in the mammary gland point to multiple potential
roles, to ensure the appropriate growth, health and survival of the
progeny of mammals and, at the same time, reflect structural
determinants stemming from the chemical properties of these
compounds. This has required adapting separate processes for
effective management of non-polar substances in the polar envi-
ronment of the cell, not only during their biosynthesis and accu-
mulation in the cell interior and secretion of intracytoplasmic lipid
droplets outside the cell, but also during digestion in a progeny’s
body. These processes have to be strictly coordinated and
phospholipids play an important role in these processes.
The digestion of lipid substances proceeds along with diges-
tion of other dietary components. As a result of complex phys-
icochemical mechanisms, this leads to the transformation of
non-polar compounds into more polar components, which are
capable of overcoming the unstirred layer of fluid on the surface
of epithelial cells of the intestine and enables their absorption
by villi [4]. Hence, the structure and properties of lipid in milk
is strictly related to the processes of their digestion and have
evolved together, adjusting to each other in order to maximize
the effectiveness of both processes. An example of such an
adjustment may be the high degree of milk fat dispersion which
results from mechanisms leading to the formation of fat glob-
ules as well as through increasing the interface, which allows
for more efficient access of lipase to a lipid globule interior and
more effective degradation of the substrate, i.e. triacylglycer-
ols present inside lipid droplets.
Our knowledge of the properties, composition and occurrence
of particular groups of lipid compounds is expanding due to the
application of such analytical methods as chromatography, mass
spectrometry (MS) and nuclear magnetic resonance (NMR)
spectroscopy. Complete databases of lipid compounds typical
of particular tissues have also been established [5, 6]. This unique
multiplicity of structures and their diversified composition also
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indicate the variety of functions they play and their complex roles
in a living organism. Only determination of the correlations be-
tween their composition and biological properties will allow
exploiting this knowledge to improve the quality of foods and
prevent and treat many different diseases.
This review investigates the properties of phospholipid
compounds occurring in milk and their effect on the structure
of a milk fat globule and identifies their potential role during
milk secretion in the mammary gland.
Composition and Structure of Milk Lipids
Lipids and Proteins of the Milk Fat Globule
The content of lipid compounds in milk is species-dependent
and ranges from 3.8 to 3.9% in human milk and from 3 to 5%
in cow’s milk. They occur in the form of the so-called milk fat
globules with sizes ranging from 0.2–15 μm. Inside the
globules, there are triacylglycerols which represent 97–98%
of milk lipids [7]. They are coated with a triple phospholipid-
protein layer which is 10–20 nm in diameter, the so-called milk
fat globule membrane (MFGM). This triple membrane is a
unique structure in biology; among all known cells, only the
epithelial cells of the mammary gland are capable of secreting
intracytoplasmic lipid droplets outside a cell [8]. The mem-
brane of MFG constitutes 2–6% of the total globule weight
and is composed mainly of proteins and phospholipid, which
represents at least 90% of the membrane. The content of pro-
teins in themembrane is estimated at 22–60% [9–11], about 1–
2% of the total protein weight in milk. The main proteins of the
milk fat globule membrane are presented in Table 1.
Some of the membrane proteins are glycoproteins and
can be covalently linked with phospholipids or neutral
lipids [9]. Apart from these major proteins, membrane
preparations also contain many other proteins, such as: en-
zymes, immunoglobulins, MHC proteins and proteins derived
from the cytoplasm of epithelial cells of the mammary gland
and leucocytes [12, 13]. The lipid composition of the milk fat
globule membrane is presented in Table 2.
Although the lipid of themilk fat globulemembrane comprises
both neutral and polar lipids, however, the triacylglycerol fraction
may originate from contamination by the core of fat globule
during isolation of the membrane [15]. The content of di-,
monoacylglycerols and free fatty acids may also result from
the enzymatic activities during preparation of the sample.
The main polar lipids of milk consist of phospho- and
sphingolipids. They are basic components of the membranes
due to their amphiphilic structure. The first are built of glycerol
esterified at two sites with fatty acids (FA) and with phosphate
with a different organic group (e.g. serine, choline) attached at
the third site in the glycerol backbone. For sphingolipids, the
structure varies and is based on a sphingosine (the sphingoid
base), i.e. a long-chain aliphatic amine which additionally con-
tains two or three hydroxyl groups. The attachment of a fatty
acid to an amine group results in the formation of ceramide.
After the addition of the organophosphate group, a
sphingophospholipid is formed. Once phosphocholine is at-
tached to the ceramide, sphingomyelin is formed, whereas a
sphingoglycolipid is formed upon the attachment of a saccharide
Table 1 The main protein
components of the bovinemilk fat
globule membrane
(adapted from Ref. [12])
Proteins (other names or abbreviations) Molecular weight, (Da)
Mucin 1 (MUC 1) 120,000–220,000
Xanthine dehydrogenase/oxidase (XDH/XO) 300,000 (2 × 150,000)
Periodic acid Schiff III (PAS III, Mucin 15, MUC 15) 95,000–100,000
CD 36 (PAS IV) 76,000–78,000
Butyrophilin (BTN) 66,000–67,000
Periodic acid Schiff (PAS VI/VII, lactadherin, milk fat globule-EGF factor 8) 43,000–59,000
Adipophilin (ADPH) 52,000
Fatty acid binding protein (FABP) 13,000
Table 2 Lipid composition of the bovine milk fat globule membrane
(adapted from Ref. [11, 14])
Lipid component % of total lipids of the MFGM
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group [16, 17]. Phospholipids constitute ca. 1% of milk fat [18]
and most of them are formed within the endoplasmic reticulum
(ER) [19].
Structural Features of the Milk Fat Globules
The structure of a fat globule membrane is asymmetric – the
internal and external surfaces differ from each other with their
composition, which is due to the wide range of functions
served by a given surface. The components of the MFGM
are arranged so that the external part of the bilayer is consti-
tuted mainly by phospholipids containing choline (PC
and SM) as well as glycolipids, cerebrosides, and gan-
gliosides (molecules containing polar components as saccha-
ride residues), directed towards the aqueous environ-
ment, whereas the interior surface of the bilayer contains
phosphatidylethanolamine, phosphatidylinositol and
phosphatidylserine [9, 20].
Structurally, the MFGM is a so-called liquid lipid-protein
mosaic. According to the widely-accepted current model of
the membrane, the so-called Bliquid lipid-protein mosaic^,
proteins are immersed or flow in a liquid bilayer of spatially-
oriented lipids [21]. Membrane components (both proteins
and phospholipids) are capable of lateral diffusion if not
coupled with components of the cytoskeleton of a cell. For
phospholipids, diffusion across the membrane is also likely. In
the bilayer, phospholipids may enter into specific interactions
with proteins, thereby affecting their biological properties and
functions. Apart from that, local areas with a composition and
properties differing from other areas with incidental composi-
tion may also occur in the membrane. These are so-called
Blipid rafts^ which may be isolated from the membrane with
appropriately selected solvents [22]. Agglomerations of
sphingolipids with cholesterol may serve as an example in this
case. Sphingolipids display some typical traits that distinguish
them from other phospholipids. They contain relatively more
long-chain and saturated fatty acids, which allows for dense
packing of the hydrocarbon chains next to one another. In
addition, due to structural matching, they show affinity to
cholesterol and may form lateral bonds with it, based on both
polar and non-polar interactions. For this reason, these do-
mains do not occur in a liquid state, unlike the remaining part
of the membrane. As the lateral diffusion of components of
these domains is still likely, it is not a solid state either (below
melting point). It is assumed that they occur in an intermediate
state, the so-called liquid ordered phase (Lo) [23]. Long chain
n-3 polyunsaturated fatty acids (PUFA) can modify the mo-
lecular order within cholesterol-enriched lipid microdomains.
Recent studies have shown that eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) upon incorporation into the
plasma membrane exert different structural effects when in-
corporated into phosphatidylethanolamines (PE) compared to
phosphatidylcholines (PC). DHA-containing PE moves into a
non-raft region and push cholesterol into the rafts and increase
molecular order within the membrane, while DHA-containing
PC locate into the rafts, displace cholesterol from rafts and the
molecular order in membrane decreases [24]. Proteins and
glycolipids may also occur in the rafts or on their rims. The
grouping of components with similar properties is consistent
with the principle of energy minimization. Regarding their
functional properties, they may take part in many vital pro-
cesses of a cell involving signal transmission or inter-cell
communication. The action of several anticarcinogenic drugs
is based on the induction of cancer cell apoptosis through
disruption of the integral structure of lipid rafts in their mem-
brane [25]. The presence of lipid rafts was also observed in
MFG [26], although their role and function in nutrition re-
mains unexplained.
Considering the structure itself and structure-related physi-
cochemical properties, the role of phospholipids includes sta-
bilization of milk fat in the dispersed form, prevention of floc-
culation and coalescence of globules, as well as protection
against adverse effects of lipases. Apart from their structural
functions in the membrane, phospholipids are also significant
in nutrition in the period of infant development. Several studies
have demonstrated the high biological activity of these com-
pounds and their metabolites, which allows classifying them as
components with a positive effect upon human health [20].
Their biological properties have been widely discussed in re-
view articles [27–29]. For example, treatment with
phosphatidylserine-containing liposomes was shown to posi-
tively influence patients suffering from Alzheimer’s disease
[30]. Sphingomyelin was shown to present potentially anti-
cancer properties [31]. Other examples include the antitoxic
properties of phosphatidylcholine [32] and the positive effect
on the development and functioning of the nervous system
[33], as well as the anti-bacterial properties of phospholipid
and triacylglycerols hydrolysis products [34]. Also phospho-
lipids containing (n-3) fatty acids may have protective proper-
ties against obesity in childhood [35].
Structural Determinants of Milk Fat Globules
Secretion – the Role of Phospholipids
Basic Properties of Polar Lipids
In terms of chemical structure, molecules present in the world
around us may be divided into those which possess a charge
and those which have no charge in their structure. The posses-
sion of charge results in specified properties that are referred to
as hydrophilic and lipophilic, respectively. Phospholipids
merge these two properties and constitute a structural hybrid
composed of a part which possesses a charge and a part with no
charge, the so-called Bhydrophilic head and hydrophobic tail^.
These are referred to as amphipathic compounds. This structure
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determines the specific properties of phospholipids. As each
system tends to form the lowest energy state, the most benefi-
cial would be if the hydrophilic part could contact the hydro-
philic environment and avoid the hydrophobic environment.
By analogy, contact of the hydrophobic part with the hydro-
philic environment would be energetically unbeneficial. In an
aqueous environment, phospholipid orientation enables the hy-
drophilic part to contact water and simultaneously the hydro-
phobic part to hide from contact with water. Such conditions are
met when phospholipids are at the water surface and when their
hydrophilic part is directed towards water. In this case, the
surface tension of the water decreases. Another potential ar-
rangement is a lipid bilayer in which the hydrophobic parts
are hidden from contact with water inside the bilayer. If such
a bilayer binds into a spherical structure, a liposome will form
that separates the two spaces. This ability has resulted in the
possibility of developing a structure separated from the external
environment, i.e. a cell with a separating bilayer called a bio-
logical membrane. Considering that one tip of the phospho-
lipids is polar and the other is non-polar, an ideal situation
would be the hydrophilic part having contact with the hydro-
philic environment and the hydrophobic part having contact
with the hydrophobic environment. This is likely when the
phospholipid is at the contact site of these two environments,
i.e. at the so-called interface. Another property of phospholipids
stemming from their structure is their emulsifying capability,
which consists in the ability to disperse the non-polar molecules
in the polar environment in a dispersed form (or otherwise, i.e.
dispersing polar molecules in a non-polar environment).
Although the general structure of phospholipids is similar,
the significant variations in their chemical make-up in biolog-
ical membranes entail some differences in their properties.
These properties depend on both the length and saturation of
attached fatty acids and the type and polarity of the head
group. Different studies of these properties in artificial mem-
brane systems indicate that the chain length, degree of
unsaturation and properties of the polar head group and the
type of pairing of the hydrocarbon chains may affect the rate
of diffusion and transport through the membrane [36].
Phospholipid non-polar tails associate with the involvement
of van der Waals hydrophobic interactions, which is of great
importance for the integrity of the biological membranes.
These interactions increase with an increase in the acyl chain
length, but decrease with an increase in the number of unsat-
urated bonds in the hydrocarbon chain. Double bonds in the
hydrocarbon chains introduce a kinkwhich disrupts part of the
hydrophobic interactions and increases the fluidity of the
membrane. The double bond in membrane phospholipids is
usually in the cis configuration. Polar head groups contact
with water environment and determine the net surface charge
of the membrane. Electrostatic forces may also play a role in
stabilizing the integrity of the membrane, but may also allow
for binding other polar lipids or proteins.
These general basic examples show how the specified
properties and characteristics of phospholipids determine their
behaviour in various environments. They also point to some
limitations a cell has to overcome when using non-polar sub-
stances in a polar environment as well as to the specific role of
phospholipids in these processes.
Regulation of Milk Fat Biosynthesis
Processes related to lipid metabolism and leading to the bio-
synthesis of milk fat include a number of steps. One of the
main constituents of milk triacylglycerols and phospholipids
are fatty acids. They may come from ingested food or mater-
nal fat stores. In addition, some fatty acids (saturatedmainly of
10–14 carbon atoms) may be synthesized de novo in the liver,
mammary gland and other tissues [37]. Fatty acids from
ingested food after absorption by the intestinal villi in the
small intestine, undergo re-esterification into triacylglycerol
and in the form of chylomicrons are delivered to the mammary
gland [38]. During periods of a shortage of dietary fat, triac-
ylglycerols are transported from the liver to the mammary
gland in the form of VLDL (very low density lipoproteins).
Fatty acids may also be transported in the body with albumin
[40] The main protein component of both chylomicrons and
VLDL is apolipoprotein B, which interacts with lipoprotein
receptors on the surface ofmammary cells [39]. Fatty acids are
then released under the influence of lipoprotein lipase (LPL)
and may cross the membrane and enter the cell [40]. During
lactation, the level of LPL is increased in the mammary gland
and decreased in adipose tissue, indicating increased uti-
lization of fatty acids in the mammary gland [41]. CD36 pro-
tein may play an important role in the import of fatty acids into
the cell [42].
After crossing the membrane, fatty acids under the influence
of acyl-CoA synthetase are activated into the form of an acyl
CoA. The activated fatty acids connected to specific cytosolic
FABP (fatty acid binding protein) are transported to intracellu-
lar organelles for further reactions. Depending on the needs of
the cells, fatty acids can be desaturated under the influence of
stearoyl-CoA desaturase (SCD) and/or be converted into tri-
glycerides, phospholipids or cholesterol esters [42]. Glycerol
phosphate acyltransferase (GPAT), acylglycerolphosphate acyl-
transferase (AGPAT), lipin (phosphatidate phosphatase) and
diacylglycerol acyltransferase (DGAT) are responsible for the
conversion of glycerol-3-phosphate to lysophosphatidic acid,
phosphatidic acid, di- and triacylglycerol, respectively, and
are present in the membrane of the endoplasmic reticulum.
Figure 1 summarizes these reactions, which lead to biosynthe-
sis of triacylglycerols as well as the Kennedy CDP-choline
pathway and Lands` remodeling cycle, leading to phosphati-
dylcholine biosynthesis [43–45].
The biosynthesis of milk fat is a complex process which
requires coordinated control of many cellular processes and
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metabolic pathways occurring at different stages of develop-
ment and functioning of the mammary gland. These processes
are regulated by the so-called gene networks, which are inter-
actions and relationships between transcription factors and
other regulatory elements that affect the expression of specific
genes [42, 46]. During each pregnancy changes in hormone
levels induce cycles of growth, lactation and involution, dur-
ing which mammary epithelial cells proliferate and differenti-
ate to produce milk and then die in the apoptotic process [47].
Prolactin and oxytocin are essential hormones for the produc-
tion and secretion of milk during the lactation period [48, 49].
Binding of prolactin to its receptor (PRLR) on the surface of
cells of the mammary gland results in its dimerization.
Dimerization leads to activation of the Janus tyrosine kinase,
receptor phosphorylation and dimerization and phosphoryla-
tion of Stat transcription factors Stat 5a and 5b. In this form,
these factors can move into the nucleus and, by the addition to
the appropriate regulatory DNA sequences, activate milk pro-
teins genes [50]. Naylor et al. [51] used transcript profiling of
three mouse models that exhibit failure of prolactin secretory
activation and observed changes in gene expression. They
found reduction in expression of many genes representing
milk proteins, metabolism, immune response, key transcrip-
tion factors and also lipid, cholesterol and fatty acid biosyn-
thetic enzymes.
Proteins belonging to the family of SREBP proteins are
transcription factors binding sterol regulatory element (sterol
regulatory element-binding proteins, SREBP). They regulate
the expression of genes involved in cholesterol and lipid ho-
meostasis. Their regulatory domain interacts with the SCAP
protein (SREBP cleavage activating protein) which acts as a
sensor responsive to the level of cholesterol. When the choles-
terol level is lowered, the protein SCAP escorts SREBP protein
to the Golgi apparatus where, under the influence of two spe-
cific proteases, the domain that interacts with DNA is released.
This fragment after dimerization translocates to the nucleus
and, when attached to the promoter regions of DNA, activates
the entire group of genes responsible for the synthesis of cho-
lesterol, fatty acids, triglycerides, phospholipids and NADPH
(as a cofactor necessary for the synthesis of these compounds)
[52]. Rudolph et al. [53] studied role of sterol regulatory ele-
ment binding proteins in regulation of fatty acid synthesis using
mouse models with mammary epithelial cell-specific deletion
of SCAP and SREBF1 isoforms. They identified some target
Fig. 1 General scheme for non-polar and polar lipid biosynthesis (based
on Ref. [43–45]). Glycerol phosphate pathway for synthesis of triacylglyc-
erols. Two subsequent acylation steps of glycerol phosphate by glycerol 3-
phosphate acyltransferase (GPAT) and 1-acylglycerol-3-phosphate acyl-
transferase (AGPAT) lead to phosphatidic acid (PA). A lipin family enzyme
then converts PA into diacylglycerol (DAG). DAG can enter the Kennedy
pathway for phosphatidylcholine or after the addition of a third acyl chain
can be converted to triacylglycerol (TAG) through the action of diacylglyc-
erol acyltransferase (DGAT). The Kennedy pathway of PC. After phos-
phorylat ion of choline catalysed by choline kinase (CK)
CTP:phosphocholine cytidylyltransferase (CCT) catalyses activation of
phosphocholine with cytidine triphosphate (CTP). This activated form is
transferred to DAG and PC is formed. This reaction is catalysed by
cholinephosphotransferase (CPT). The remodeling Lands cycle for PC.
Phospholipase A2 (PLA2) hydrolyses the acyl chain from the sn-2 position
of a PC and generates a lysophosphatidylcholine (LPC). Subsequently
lysophosphatidylcholine acyltransferase (LPCAT) catalyses reacylation of
LPC with a second fatty acid (in the form of fatty acyl-CoA). Other abbre-
viations: ATP-adenosine triphosphate; ADP-adenosine diphosphate; CDP-
cytidine diphosphate; CMP-cytidine monophosphate; PP-diphosphate;
CoA-coenzyme A
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genes of SCAP and SREBF proteins, but the obtained results
also suggest a role for additional regulatory mechanism for de
novo fatty acid synthesis in the mammary gland.
Another regulator of lipidmetabolism in themammary gland
may be a PPAR γ protein (peroxisome proliferator-activated
receptor γ). This protein is involved in the process of adipocyte
differentiation and its expression can be stimulated by either
insulin or SREBP-1. It belongs to the transcription factors acti-
vated by lipophilic agents and regulates the expression of genes
related to the metabolism of fats, proteins and carbohydrates
[54]. It has been shown that the activity of many enzymes (of
their various isoforms) is governed largely by complexes of
fatty acids with FABP (fatty acid binding protein) which deter-
mines their further utilization [55]. These complexes can also
affect gene expression by interacting with the PPAR γ [42].
While the relationship between transcription factors regulat-
ing the biosynthesis of milk fat has not been precisely defined,
many important elements playing a primary role in this regula-
tion have been identified. Most of research concentrated on the
regulation of fatty acid or triacylglycerol synthesis. For exam-
ple Cases et al. [56] showed that mice lacking the triglyceride
synthesis enzyme acyl CoA:diacylglycerol transferase 1
(DGAT) are characterized by impaired mammary gland devel-
opment. Contrary, not much research concentrated on the role
of phospholipids biosynthesis regulation in themammary gland
functioning. Doria et al. [57] used genomic and lipidomic ap-
proaches to characterize lipid metabolism changes in mammary
epithelial cells undergoing proliferation and differentiation and
study correlation to breast cancer survival. They showed that
many genes involved in phospholipid synthesis and metabo-
lism were upregulated in differentiating mammary cells and
also correlated with breast cancer survival.
This brief overview of some elements relating to the regu-
lation of milk fat biosynthesis indicates the need for further
research and greater attention to the role of phospholipid bio-
synthesis in the functioning of the mammary gland as well as
in relation to the overall metabolism of lipids.
Formation of Intracellular Lipid Droplets
The formation of lipid droplets in the cytoplasm is linked with
endoplasmic reticulum. Also phospholipid synthesis occurs in
the cytosol in close proximity to the ER membrane. After
incorporation into the membrane, fragments of the membrane
can eventually bud off and transport phospholipids across the
cell. Triacylglycerols accumulate on the surface or inside the
ER membrane. By forming a Bbulge^, they may detach from
the ER membrane and migrate to the cytoplasm and become
surrounded by the outer cytosolic part of the ER membrane
which contains polar lipids and proteins [58, 59]. This mono-
layer separates the lipid core of a lipid droplet from the cell’s
interior. Adipophilin (ADPH) belongs to the PAT proteins
(perilipin, adipophilin and TIP47) family and is known to
specifically localize to cytoplasmic lipid droplet surface and
regulate the access to the droplet interior in mammary gland
[60]. In the cytoplasm, the small droplets fuse with each other,
forming droplets of various larger sizes. Although the mech-
anisms that regulate this process are still unclear, it has been
demonstrated that small droplets may merge into larger drop-
lets, whereas the larger ones are incapable of fusion [8]. The
SNAP (soluble NSF attachment protein) and SNARE (soluble
N-ethylmaleimide-sensitive-factor (NSF)-attachment protein
receptor) proteins may participate in the fusion process of
intracytoplasmic lipid droplets [61]. Other proteins may be
also linked to the size of lipid droplets [62]. Cell death-
inducing DFF45-like effector (CIDE) family proteins have
recently gained attention as key regulators of lipid storage
[63]. It was shown that cells deficient in Fsp27 (fat
specific protein of 27 kDa) or Cidea, members of CIDE fam-
ily, accumulate many small intracellular lipid droplets [64].
The FITM (fat storage inducing transmembrane) proteins are
evolutionarily-conserved membrane proteins. The breakdown
of these proteins leads to reduced storage of triacylglycerols
[65], while their overexpression significantly increases TAG
storage and droplet size [66]. Perilipin 1 (another PAT protein)
is highly expressed in adipocytes, where it locates on the sur-
face of lipid droplets and is a well-established regulator of
lipolysis in adipocytes [67]. These proteins are known regula-
tors of processes related to the functioning of lipid droplets,
but little is known about the role of phospholipids in these
processes and possible interactions between proteins and
lipids at the interface.
Afterwards, by means of an unknown mechanism, the
droplets are transported to the apical part of a secretory cell
membrane. Studies have demonstrated high contents of mi-
crotubules, actin microfilaments and intermediate filaments in
the apical regions of secretory cells [68, 69], as well as the
presence of proteins interacting with the cytoskeleton in the
intracellular lipid droplets [70]. The involvement of cytoskel-
eton elements in the intracellular transport of lipid droplets
therefore seems likely.
Crossing the Plasma Membrane - the Phospholipid Flux
is Essential for Continuity of Milk Component Secretion
Fat globules are intracytoplasmic lipid droplets secreted out-
side the milk-producing cells. These are the only known
cells capable of secreting whole lipid droplets outside
the cell. It has required Bdeveloping^ a separate mechanism
enabling this process.
The lipid droplets are secreted outside the cell, probably
according to a unique mechanism different from classical exo-
cytosis. This mechanism differs completely from the secretion
of triacylglycerols by other cells (e.g. secretion of chylomi-
crons or other lipoproteins), although two potential mecha-
nisms have been postulated.
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In the classical model, alveoli are subject to fusion, which
leads to the formation of an intracytoplasmic vacuole contain-
ing both casein micelles and lipid droplets. The contents of
these vacuoles are then secreted outside the cell via classical
exocytosis [71]. A potential scheme of such a mechanism
considering the flux of phospholipids is presented in Fig. 2a.
The second, currently accepted potential mechanism as-
sumes that lipid droplets are coated with a cellular membrane
originating from the external, apical part of the secretory cells
and, in this way, gain an additional lipid bilayer [72]. This
bilayer contains multiple membrane proteins, some of which
take part in the secretion of lipid droplets. A significant role
may be ascribed in this case to butyrophilin and xanthine
dehydrogenase/oxidase (XDH). These proteins have been
found to interact with each other during secretion of lipid
droplets because they occur in stable molar ratios in a mem-
brane of lipid droplets, among others [8]. As butyrophilin is
linked with a cell membrane and XDH is a cytosolic enzyme,
interactions may occur between the cytosol part of
butyrophilin and XDH during lipid droplet secretion, which
results in the formation of complexes on the droplet surface
with disulfide bridges. Adipophilin (ADPH) may also partic-
ipate in these interactions and in the formation of a protein
coat on a droplet surface [8, 73]. These complexes may initiate
the process of droplet coating with a membrane and its secre-
tion outside the cell (Fig. 2b).
This mechanism results in the formation of a specific struc-
ture and, although this unique structure results from the mech-
anism of lipid droplet secretion outside the cell, this mecha-
nism is also expected to ensure specified benefits to the prog-
eny. It is known that the lipid droplets secretion process prob-
ably follows the mechanisms presented in Fig. 2b. In this
process, the droplet is coated by the cellular membrane and
after membrane fusion it is secreted as a droplet coated with a
triple lipid layer [72]. This mechanism may result from some
limitations, but it may also yield some benefits to the progeny.
Fig. 2 Theoretically possible
schemes of milk fat globule
secretion. In Fig. 2a, the classical
model of secretion of milk
components with the formation of
an intracytoplasmic vacuole
containing both casein micelles
and lipid droplets. The content of
this vacuole is then secreted
outside the cell via exocytosis.
Fig 2b presents the modern,
currently accepted model of
secretion of milk components. In
this model intracellular lipid
droplets contact directly with the
apical plasma membrane and are
secreted outside the cell
surrounded by a triple layer of
phospholipids. Considering the
flux of phospholipid, only the
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Above all, it ensures the flux of phospholipids in the cell
secreting lipid droplets outside the cell which, in turn, allows
for effective secretion of all milk components, as depicted in
Fig. 3a. On the one hand, the vesicles provide water-soluble
substances in the form of transporting liposomes coated with a
double lipid layer. Proteins synthesized in a rough endoplas-
mic reticulum (RER) are secreted in this way. After translation
and penetration into the interior of reticulum, the primary
structures of proteins emerge in the transporting vesicles and
are transported to the Golgi apparatus, from where (after mod-
ifications and development of the specific protein structure)
they migrate again in transporting vesicles to the apical part of
the cellular membrane to be eventually secreted outside the
cell. The contents of these structures are secreted according to
the mechanism of classical exocytosis, after the fusion of the
transporting vesicle with the cellular membrane [74]. In this
case, the membrane material is delivered with the vesicles and
remains in the apical part of the cellular membrane. In this
way, the membrane material would shortly be in excess com-
pared to the surface area (or capacity) of the membrane. Such
a process could, however, not be endless. In turn, while being
secreted, the lipid droplets are coated with a double membrane
and take part of the membrane material away with them. This
mechanism of lipid droplet secretion allows the continuity of
the milk production process to be maintained. In addition, the
secretion mechanism of both hydrophilic and lipophilic sub-
stances coordinated in this way enables a stable level of phos-
pholipids in the membrane to be maintained as well as mem-
brane continuity and non-intermittent transport (Fig. 3b). To
the author’s knowledge, this observation has not been reported
in the literature to date. Considering the above, the mechanism
of secretion presented in Fig. 2a seems rather unlikely. In this
case, a one-way flux of phospholipids and accumulation of
their excess quantities in the apical part of the mem-
brane would occur. A continuous process would be pos-
sible on condition that some mechanism would be developed
allowing for discharge or removal of phospholipids from the
membrane, which has rather not been corroborated by study
results.
Milk production is a great challenge for mammary epithe-
lial cells. It requires well-coordinated uptake of systemic
building blocks for the production of nutrient-rich milk. The
observations discussed above have shed some new light on
the organization and coordination of the milk production pro-
cess in the mammary gland. Considering the flux of phospho-
lipids and their indispensability inside the epithelial cells of
the mammary gland, they may be one of the key elements in
regulating the secretion of milk components.
The Milk Fat Globule Size as a Result of Balanced
Biosynthesis of Polar and Neutral Lipids
The availability of polar lipids may also greatly affect the size
of MFG. Greater availability of phospholipids may enable
better dispersion of triacylglycerols in the form of smaller
MFG which, in turn, will be reflected in the better availability
of fat and better digestion in the organism of the progeny.
By this means, both the flux and availability of phospho-
lipids may determine the ratio of hydrophilic to lipophilic sub-
stances in milk, simultaneously enabling their coordination
Fig. 3 Scheme of secretion of
milk components (Fig. 3a – based
on Ref. [72]). In Fig. 3b, arrows
indicate the flux of phospholipids
to and from the apical membrane
of the mammary gland. In this
model milk fat globules and water
soluble milk components are
secreted separately, by two
distinct pathways (I and II,
respectively). These two
pathways enable replenishing the
phospholipid content of the apical
membrane, maintaining its
constant composition and,
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and uninterrupted secretion. The specified volume of
transporting vesicles corresponds to the specified amount of
the membrane material that will be attached to the apical mem-
brane. This indicates that a specific amount of phospholipids
may be used for the secretion of a specified amount (volume)
of fat.
Taking into account the changes in milk composition dur-
ing transition from colostrum to the mature milk, a negative
correlation may be observed between the size of fat globules
and the content of phospholipids. Using formulas for sphere
surface area and volume, the correlation between the number
of formed globules with uniform size and the formed surface
of milk fat may be expressed with the following formula:
y ¼ 4:835 x0:333
where: x denotes the number of globules formed and y de-
notes globule surface area.
According to the formula, assuming a density equal
to 1 g/cm3, a surface of 48.34 cm2 will be achieved once 1000
globules of the same size are produced from 1 g of fat. An
increase in the number of produced globules to 2000 will
result in surface increase to 60.90 cm2. This formula approx-
imately shows the increasing demand for phospholipids (as a
monolayer) at an increasing degree of dispersion for a speci-
fied amount of triacylglycerols. It indicates that an appropriate
amount of phospholipids may be an element controlling fat
dispersion degree. Changes in globule size may be determined
by the availability of phospholipids (especially in a triple lay-
er), but also have to meet the specific needs of a new-born for
phospholipids and triacylglycerols, respectively. This demand
may vary throughout the developmental process and, initially,
during intensive development of the alimentary and nervous
systems a relatively higher supply of phospholipids may be of
greater significance. Furthermore, phospholipids contain sig-
nificant amounts of polyunsaturated fatty acids (PUFA),
which are an indispensable component of cellular membranes
and are essential for proper brain and retina development in
neonates [75]. Zou et al. [76] investigated changes in the lipid
composition of human milk during lactation. They showed
that fat content increased during lactation and colostrum milk
also constituted a higher content in PUFA (ω-6, long chainω-
6 and ω-3) than mature milk, which is of special importance
during neonatal development. Most likely, all of these factors
do play a role, are correlated with each other and are the result
of adaptation in the evolutionary process. However, the con-
tents of phospholipids and triacylglycerols in milk are strictly
correlated and are Bexpressed^ by the size of MFG.
Considering the aforementioned limitations, the phospho-
lipids supply to a new-born’s body may be enhanced through
so-called Blactosomes^, i.e. small lipid globules free of triac-
ylglycerols, the presence of which has recently been detected
in milk [77]. They may also balance the flux of phospholipids
by removing their excess from the membrane produced after
the supply of liposomes with water soluble components of
milk and maintain the continuity of milk production.
The process during which a fat globule is coated with a
triple phospholipid membrane may yield some benefits to
the progeny ingesting milk. Fat globules coated with the triple
phospholipid layer provide significantly higher (ca. threefold)
amounts of phospholipids compared to the monolayer. For a
Fig. 4 The process of fusion or breakdown of intracytoplasmic lipid
droplets requires changes in the content of phospholipids in the
membrane. The merging of droplets leads to an excess of phospholipids
which have to be removed from the membrane as the volume of the TAG
droplet increases. Conversely, the breakdown into smaller droplets requires
additional amounts of phospholipids to contain the smaller sized CLD
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developing young organism, the appropriate amount of phos-
pholipids provided with food may be of key significance for
the proper development of not only the nervous system, but
the organism as a whole.
During intensified production of milk fat in the mammary
gland, lipid droplets are also subject to coalescence and fusing
into larger droplets in a cell’s interior and, with their sizes
increased, they are then secreted outside the cell. As men-
tioned above, a high degree of lipid droplet dispersion inside
cells of the mammary gland, with a concomitant increased
intensive production of MFG, requires a high supply of phos-
pholipids. One of the means to reduce the demand for phos-
pholipids with a the simultaneously enhanced production of
milk fat involves a reduction of fat dispersion degree via co-
alescence and the formation of larger fat globules. For such
globules, the surface area-to-weight ratio is lower and, resul-
tantly, the demand for phospholipids is reduced. In other
words, with a specified Bpool^ of phospholipids, the increase
in fat globule size allows for a significantly greater secretion
of milk fat. Thus, the availability of phospholipids may affect
the size of intracytoplasmic lipid droplets and may be one of
the factors regulating their size.
The above considerations have been confirmed in conduct-
ed research. Lopez et al. [78] pointed to a correlation between
the content of polar lipids and the surface and size of fat
globules. The secretion of small globules leads to a higher
MFGM/TAG ratio compared to large fat globules. In turn,
Argov et al. [79] demonstrated that the polar lipids-to-
triacylglycerols ratio (PL/TAG ratio) decreased along with
an increasing fat content of milk. Finally, Wiking et al. [80]
demonstrated a correlation between milk fat content and fat
globule size and emphasized the availability of membrane
material as a limiting factor. These correlations also show
the significant role of phospholipids as a factor determining
fat content and fat globule size.
Changes in Fat Globule Size Require Reorganization
of the Interface Material
It is also noteworthy that the process of fusion or breakdown
of droplets into smaller ones results in an excess or deficit of
phospholipids. It seems advisable, therefore, to consider
whether the generated excess or deficit of phospholipids leads
to a stable structure characterized by insignificant loosening
(or potentially by insignificant concentration) or whether it
requires an immediate reorganization of the interface material.
However, it seems likely that the process of globule fusion
requires removing the excess of phospholipids from the inter-
face in order to ensure stability and durability of a newly-
formed system (Fig. 4). By this means, it is also possible that
the removal or incorporation of phospholipids (for example
with the action of enzymes) into the interface may enforce or
initiate the successive processes of either fusion or breakdown
of droplets into smaller ones. In this case, not only phospho-
lipid availability but also its metabolism or modifications
could be an element enabling lipid droplet size regulation in
the cell’s interior. This observation is in agreement with stud-
ies showing the role of phosphatidylcholine and phosphatidic
acid (PA) in lipid droplet size. The high content of PC is
related to small droplets and is believed to prevent coales-
cence, while only a small amount of PA, a fusogenic lipid, is
known to trigger SNARE-dependent and SNARE-
independent membrane fusion events leading to increased
droplet sizes [62, 81].
A similar mechanism, in which a key role is ascribed to
phospholipids, may be applied to regulate the size of
intracytoplasmic lipid droplets in other cells. Fat cells
(adipocytes) are characterized by considerably larger sizes of
intracytoplasmic lipid droplets. It is known that the key role in
regulating fat globule size and in management of cell lipids
reserves is played by PAT family proteins [82]. However, the
mechanism according to which they regulate the access to cell
lipids reserves and the mechanism allowing for size regulation
of intracytoplasmic lipid droplets remains unclear.
Phospholipids may be one of the factors that regulate their
size and their effective consumption by interactions with
PAT proteins. In this case, with the specified pool of phospho-
lipids and high fat content, increasing the size of lipid droplets
may prevent the unnecessary consumption of phospholipids
and ensure more effective use of the available intracellular
space. In mammary gland cells, the droplets are smaller,
which necessitates a greater amount of phospholipids.
However, in this case, of greater significance may be the pos-
sibility of droplet secretion outside the cell and providing sig-
nificant amounts of phospholipids to a developing new-born,
which is feasible by increasing the degree of milk fat disper-
sion and the triple phospholipid layer.
Summary
Through the presentation of characteristic structural traits of
milk fat globules and mechanisms linked with their secretion,
this work indicates the potential role of phospholipids in this
process. To date much work has focused on total lipid compo-
sition and how the individual fatty acid composition of milk is
altered by maternal diet or targeted gene deletion, but little is
known about phospholipid synthesis in mammary gland and its
role during lactation. The characteristic properties of phospho-
lipids make them indispensable for the secretion of not only
milk fat, but also other milk components. Since these processes
are associated with the flux and availability of phospholipids,
they have to be strictly coordinated to proceed smoothly. This
indicates a strong correlation between secretion of lipid and
water-soluble components. The structure formed as a result of
these processes, i.e. a milk fat globule, is therefore a result of
J Mammary Gland Biol Neoplasia
specified structural limitations inside the cell, the overcoming
of which enables the secretion of milk components, although it
also needs to reflect the nutritional demands of a developing
infant’s body, resulting from evolutionary adaptation.
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